Updated on 2024/11/27

写真a

 
SOBUE Akira
 
Organization
Research Institute of Environmental Medicine Division of Stress Recognition and Response Designated assistant professor
Title
Designated assistant professor

Degree 1

  1. 博士(医学) ( 2018.3   名古屋大学 ) 

Research Interests 5

  1. グリア細胞

  2. 神経炎症

  3. 行動薬理学

  4. アルツハイマー病

  5. ミクログリア

Research Areas 2

  1. Life Science / Pathophysiologic neuroscience

  2. Life Science / Pharmacology

Education 2

  1. Nagoya University   Graduate School, Division of Medical Sciences

    - 2018.3

      More details

    Country: Japan

  2. Osaka University of Pharmaceutical Sciences   Faculty of Pharmaceutical Science

    - 2014.3

      More details

    Country: Japan

Professional Memberships 6

  1. 日本認知症学会   若手研究者育成委員

  2. The International Behavioral Neuroscience Society

  3. 日本神経科学会

  4. 日本神経精神薬理学会

  5. 日本薬理学会

  6. International Society for Neurochemistry

▼display all

Committee Memberships 4

  1. 日本認知症学会   若手研究者育成委員会  

    2024.1   

  2. Frontiers in Molecular Neuroscience   Review Editor  

    2023.11   

  3. 日本認知症学会   若手研究者委員  

    2023.1 - 2023.12   

  4. International Society for Neurochemistry   Young Scientist Steering Committee Ambassador  

    2022.12   

Awards 4

  1. 第39回日本認知症学会 学会奨励賞

    2020.11   日本認知症学会  

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

  2. JSNP Excellent Presentation Award for AsCNP 2017 Bali

    2017.4   日本神経精神薬理学会  

     More details

    Award type:Award from international society, conference, symposium, etc.  Country:Indonesia

  3. 第9回NAGOYAグローバルリトリート 優秀発表賞

    2017.2   名古屋大学  

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

  4. 第18回応用薬理シンポジウム 優秀演題賞

    2016.8   応用薬理研究会  

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

 

Papers 27

  1. Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer's disease mice by controlling astrocyte activation Reviewed

    Akira Sobue, Okiru Komine, Fumito Endo, Chihiro Kakimi, Yuka Miyoshi, Noe Kawade, Seiji Watanabe, Yuko Saito, Shigeo Murayama, Takaomi C. Saido, Takashi Saito, Koji Yamanaka

    Cell death & disease   Vol. 15 ( 11 ) page: 858 - 858   2024.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41419-024-07249-6

  2. Mice with deficiency in Pcdh15, a gene associated with bipolar disorders, exhibit significantly elevated diurnal amplitudes of locomotion and body temperature Reviewed

    Daisuke Mori, Chihiro Inami, Ryosuke Ikeda, Masahito Sawahata, Shinji Urata, Sho T. Yamaguchi, Yohei Kobayashi, Kosuke Fujita, Yuko Arioka, Hiroki Okumura, Itaru Kushima, Akiko Kodama, Toshiaki Suzuki, Takashi Hirao, Akira Yoshimi, Akira Sobue, Takahiro Ito, Yukikiro Noda, Hiroyuki Mizoguchi, Taku Nagai, Kozo Kaibuchi, Shigeo Okabe, Koji Nishiguchi, Kazuhiko Kume, Kiyofumi Yamada, Norio Ozaki

    Translational psychiatry   Vol. 14 ( 1 ) page: 216 - 216   2024.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  3. Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer's disease Reviewed

    Ting Wang, Akira Sobue, Seiji Watanabe, Okiru Komine, Takaomi C Saido, Takashi Saito, Koji Yamanaka

    Journal of Neuroinflammation   Vol. 21 ( 1 ) page: 55 - 55   2024.2

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  4. Genetic background variation impacts microglial heterogeneity and disease progression in amyotrophic lateral sclerosis model mice Reviewed

    Okiru Komine, Syuhei Ohnuma, Kunihiko Hinohara, Yuichiro Hara, Mayuko Shimada, Tomohiro Akashi, Seiji Watanabe, Akira Sobue, Noe Kawade, Tomoo Ogi, Koji Yamanaka

    iScience   Vol. 27 ( 2 ) page: 108872 - 108872   2024.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  5. Mitochondria-associated membrane collapse impairs TBK1-mediated proteostatic stress response in ALS Reviewed

    Seiji Watanabe, Yuri Murata, Yasuyoshi Oka, Kotaro Oiwa, Mai Horiuchi, Yohei Iguchi, Okiru Komine, Akira Sobue, Masahisa Katsuno, Tomoo Ogi, Koji Yamanaka

    Proc Natl Acad Sci U S A .   Vol. 120   page: e2315347120 - e2315347120   2023.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  6. Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis Reviewed

    Kotaro Oiwa, Seiji Watanabe, Kazunari Onodera, Yohei Iguchi, Yukako Kinoshita, Okiru Komine, Akira Sobue, Yohei Okada, Masahisa Katsuno, Koji Yamanaka

    Science Advances   Vol. 9 ( 31 )   2023.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  7. Neuroinflammation in Alzheimer's disease: microglial signature and their relevance to disease Invited Reviewed

    Akira Sobue, Okiru Komine, Koji Yamanaka

    Inflammation and regeneration   Vol. 43 ( 1 ) page: 26 - 26   2023.5

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: https://doi.org/10.1186/s41232-023-00277-3

  8. Sigma-1 receptor maintains ATAD3A as a monomer to inhibit mitochondrial fragmentation at the mitochondria-associated membrane in amyotrophic lateral sclerosis. Reviewed

    Seiji Watanabe, Mai Horiuchi, Yuri Murata, Okiru Komine, Noe Kawade, Akira Sobue, Koji Yamanaka

    Neurobiology of disease   Vol. 179   page: 106031   2023.2

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.nbd.2023.106031

  9. Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia Reviewed

    Saeko Takase, Jingzhu Liao, Yue Liu, Rinako Tanaka, Yasuhiro Miyagawa, Masahito Sawahata, Akira Sobue, Hiroyuki Mizoguchi, Taku Nagai, Kozo Kaibuchi, Norio Ozaki, Kiyofumi Yamada

    European Journal of Pharmacology     page: 175207 - 175207   2022.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.ejphar.2022.175207

  10. Novel reporters of mitochondria-associated membranes (MAM), MAMtrackers, demonstrate MAM disruption as a common pathological feature in amyotrophic lateral sclerosis Reviewed

    Sakai S, Watanabe S, Komine O, Sobue A, Yamanaka K.

    FASEB J .   Vol. 35 ( 7 ) page: e21688   2021.7

     More details

    Language:English  

    DOI: 10.1096/fj.202100137R.

  11. Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons. Reviewed

    Hada K, Wulaer B, Nagai T, Itoh N, Sawahata M, Sobue A, Mizoguchi H, Mori D, Kushima I, Nabeshima T, Ozaki N, Yamada K

    Molecular brain   Vol. 14 ( 1 ) page: 21 - 21   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s13041-021-00735-4

  12. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease Reviewed

    Sobue A, Komine O, Hara Y, Endo F, Mizoguchi H, Watanabe S, Murayama S, Saito T, Saido TC, Sahara N, Higuchi M, Ogi T, Yamanaka K.

    Acta neuropathologica communications   Vol. 9 ( 1 ) page: 1   2021.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  13. Analysis of Reelin signaling and neurodevelopmental trajectory in primary cultured cortical neurons with RELN deletion identified in schizophrenia Reviewed

    Tsuneura Y, Sawahata M, Itoh N, Miyajima R, Mori D, Kohno T, Hattori M, Sobue A, Nagai T, Mizoguchi H, Nabeshima T, Ozaki N, Yamada K

    Neurochemistry international     page: 104954   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.neuint.2020.104954.

  14. Overexpression of astroglial major histocompatibility complex class I in the medial prefrontal cortex impairs visual discrimination learning in mice Reviewed

    Wulaer B, Hada K, Sobue A, Itoh N, Nabeshima T, Nagai T, Yamada K

    Molecular brain   Vol. 13 ( 1 ) page: 170   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s13041-020-00710-5.

  15. Touchscreen-based location discrimination and paired associate learning tasks detect cognitive impairment at an early stage in an App knock-in mouse model of Alzheimer's disease Reviewed

    Saifullah MD Ali, Komine O, Dong Y, Fukumoto K, Sobue A, Endo F, Saito T, Saido T, Yamanaka K, Mizoguchi H

    Molecular Brain   Vol. 13 ( 1 ) page: 147   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s13041-020-00690-6.

  16. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43. Invited Reviewed

    Watanabe S, Inami H, Oiwa K, Murata Y, Sakai S, Komine O, Sobue A, Iguchi Y, Katsuno M, Yamanaka K

    Cell death & disease   Vol. 11 ( 10 ) page: 909 - 909   2020.10

     More details

  17. ARHGAP10, which encodes Rho GTPase-activating protein 10, is a novel gene for schizophrenia risk Reviewed

    Mariko Sekiguchi, Akira Sobue, Itaru Kushima, Chenyao Wang, Yuko Arioka, Hidekazu Kato, Akiko Kodama, Hisako Kubo, Norimichi Ito, Masahito Sawahata, Kazuhiro Hada, Ryosuke Ikeda, Mio Shinno, Chikara Mizukoshi, Keita Tsujimura, Akira Yoshimi, Kanako Ishizuka, Yuto Takasaki, Hiroki Kimura, Jingrui Xing, Yanjie Yu, Maeri Yamamoto, Takashi Okada, Emiko Shishido, Toshiya Inada, Masahiro Nakatochi, Tetsuya Takano, Keisuke Kuroda, Mutsuki Amano, Branko Aleksic, Takashi Yamomoto, Tetsushi Sakuma, Tomomi Aida, Kohichi Tanaka, Ryota Hashimoto, Makoto Arai, Masashi Ikeda, Nakao Iwata, Teppei Shimamura, Taku Nagai, Toshitaka Nabeshima, Kozo Kaibuchi, Kiyofumi Yamada, Daisuke Mori, Norio Ozaki

    Translational Psychiatry   Vol. 10 ( 1 ) page: 247   2020.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41398-020-00917-z.

  18. Ubiquitination of DNA Damage-Stalled RNAPII Promotes Transcription-Coupled Repair.

    Nakazawa Y, Hara Y, Oka Y, Komine O, van den Heuvel D, Guo C, Daigaku Y, Isono M, He Y, Shimada M, Kato K, Jia N, Hashimoto S, Kotani Y, Miyoshi Y, Tanaka M, Sobue A, Mitsutake N, Suganami T, Masuda A, Ohno K, Nakada S, Mashimo T, Yamanaka K, Luijsterburg MS, Ogi T

    Cell     2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.cell.2020.02.010

    PubMed

  19. Generation and analysis of novel Reln-deleted mouse model corresponding to exonic Reln deletion in schizophrenia.

    Sawahata M, Mori D, Arioka Y, Kubo H, Kushima I, Kitagawa K, Sobue A, Shishido E, Sekiguchi M, Kodama A, Ikeda R, Aleksic B, Kimura H, Ishizuka K, Nagai T, Kaibuchi K, Nabeshima T, Yamada K, Ozaki N

    Psychiatry and clinical neurosciences     2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.12993

    Scopus

    PubMed

  20. ALS-linked TDP-43<sup>M337V</sup> knock-in mice exhibit splicing deregulation without neurodegeneration.

    Watanabe S, Oiwa K, Murata Y, Komine O, Sobue A, Endo F, Takahashi E, Yamanaka K

    Molecular brain   Vol. 13 ( 1 ) page: 8   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s13041-020-0550-4

    PubMed

  21. Morphological changes in striatum and nucleus accumbens neurons lead to abnormal behavior in ARHGAP10 mutant mice

    Hada Kazuhiro, Ozaki Norio, Yamada Kiyofumi, Wulaer Bolati, Nagai Taku, Sbue Akira, Sawahata Masahito, Itoh Norimichi, Mori Daisuke, Kushima Itaru, Nabeshima Toshitaka

    Proceedings for Annual Meeting of The Japanese Pharmacological Society   Vol. 93 ( 0 ) page: 2-YIA-52   2020

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    <p>Schizophrenia is a severe mental illness that affects about 1% of the population. Genetic and environmental factors contribute to the development of schizophrenia. However, the exact pathoetiology remains unclear. We generated Rho GTPase-activating protein 10 (ARHGAP10) mutant mice carrying similar variations found in Japanese schizophrenia patients. In the present study, we examined spatiotemporal expression of ARHGAP10 mRNA in the brain of mice. The expression levels of ARHGAP10 mRNA were higher in the striatum (ST) and nucleus accumbens (NAc) than those in other brain regions. We performed a series of behavior test to evaluate cognitive and emotional function in ARHGAP10 mutant mice. They showed an increase in anxiety level, and manifested potentiation of methamphetamine-induced hyperlocomotion and visual discrimination task. Morphological analysis revealed that methamphetamine-treated ARHGAP10 mutant mice showed an increase in the number of c-Fos-positive-cells in the dorsal medial striatum (dmST) and NAc core than those in wild-type littermates. Golgi staining indicated that ARHGAP10 mutant mice showed an increase in neuronal complexity and spine density in the same brain regions compared to the wild-type mice. These results suggest that ARHGAP10 gene variations may lead to the development of cognitive and emotional deficits with morphological abnormality in the dmST and NAc core neurons.</p>

    DOI: 10.1254/jpssuppl.93.0_2-YIA-52

  22. Behavioral characterization of APP knock-in mice model in touchscreen-based tests aiming early detection of Alzheimer's disease.

    Saifullah MD. Ali Bin, Komine Okiru, Sobue Akira, Yamanaka Koji, Mizoguchi Hiroyuki

    Proceedings for Annual Meeting of The Japanese Pharmacological Society   Vol. 92 ( 0 ) page: 1-P-041   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    <p>Alzheimer's disease (AD) is a progressive disease characterized by loss of memory and other important mental functions. Accumulation of amyloid beta (Aβ) and fibrillary tangles are the main pathological hallmarks of this disease. Emerging data suggest that the disease process begins years before clinical diagnostic confirmation; thus, methods to improve early detection would provide opportunities for early intervention to delay progressive cognitive decline and disease onset. In our research we assessed the cognitive abilities of <i>APP</i><sup><i>NL-G-F/NL-G-F</i></sup> knock-in (<i>APP-</i>KI) mice with a touch screen-based automated test battery and water maze test. These tests are mainly dependent on the brain regions that are prone to Aβ accumulation at the earliest stages of the disease. We subjected male 6- and 11-months old <i>APP-</i>KI mice in water maze test where only older mice showed significantly worsened behavior than wild-type mice. However, using touchscreen based behavioral test it was possible to detect cognitive impairment in <i>APP-</i>KI mice at an early (4 months) stage while classical behavioral tests shows comparable results between wild-type and disease model mice. </p>

    DOI: 10.1254/jpssuppl.92.0_1-P-041

  23. Repetitive and compulsive‐like behaviors lead to cognitive dysfunction in Disc1 Δ2‐3/Δ2‐3mice Reviewed

      Vol. 17 ( 8 ) page: e12478   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/gbb.12478

  24. Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia Reviewed

    Sobue A, Kushima I, Nagai T, Shan W, Kohno T, Aleksic B, Aoyama Y, Mori D, Arioka Y, Kawano N, Yamamoto M, Hattori M, Nabeshima T, Yamada K, Ozaki N

    Sci Rep.     2018.8

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-018-31390-w

  25. Astroglial major histocompatibility complex class I following immune activation leads to behavioral and neuropathological changes Reviewed

    Sobue A, Ito N, Nagai T, Shan W, Hada K, Nakajima A, Murakami Y, Mouri A, Yamamoto Y, Nabeshima T, Saito K, Yamada K

    GLIA   Vol. 66 ( 5 ) page: 1034-1052   2018.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/glia.23299

  26. Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice Reviewed

    Shimizu S, Mizuguchi Y, Sobue A, Fujiwara M, Morimoto T, Ohno Y

    J Pharmacol Sci     2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jphs.2015.03.004

  27. 5-HT1A agonist alleviates serotonergic potentiation of extrapyramidal disorders via postsynaptic mechanisms Reviewed

    Shimizu S, Mizuguchi Y, Tatara A, Kizu T, Andatsu S, Sobue A, Fujiwara M, Morimoto T, Ohno Y

    Prog Neuropsychopharmacol Biol Psychiatry     2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pnpbp.2013.06.016

▼display all

Books 5

  1. アルツハイマー病におけるミクログリアの活性化とアミロイドβクリアランス

    祖父江顕、山中宏二( Role: Joint author)

    羊土社  2023.8 

     More details

    Responsible for pages:93-98   Language:Japanese

  2. アルツハイマー病におけるTREM2と脳内各種細胞の関連について

    祖父江顕( Role: Sole author)

    日本薬学会  2020.11 

     More details

    Language:Japanese Book type:Scholarly book

  3. 神経変性疾患におけるミクログリア. 特徴と治療標的としての展望.

    祖父江 顕、山中宏二( Role: Joint author)

    医歯薬出版株式会社  2020.6 

     More details

    Language:Japanese

  4. ストレス科学:末梢性免疫炎症反応に伴うアストロサイトにおけるMHC Class I分子の発現誘導が脳機能に及ぼす影響

    祖父江顕、永井拓、山田清文( Role: Joint author)

    日本ストレス学会  2019 

     More details

    Language:Japanese

  5. 実験医学 疾患を制御するマクロファージの多様性

    祖父江顕、遠藤史人、山中宏二( Role: Joint author)

    羊土社  2018.8 

     More details

    Language:Japanese Book type:Scholarly book

Presentations 35

  1. アルツハイマー病における神経炎症:分子病態と制御戦略 Invited

    祖父江顕

    第63回日本神経学会学術大会  2022.5.19  日本神経学会

     More details

    Event date: 2022.5

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    Venue:東京  

  2. アルツハイマー病における神経炎症:治療標的分子の探索とその制御機序

    祖父江顕、山中宏二

    第42回日本認知症学会学術集会  2023.11.24 

     More details

    Event date: 2023.11

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

  3. カンナビノイド受容体2型によるグリア細胞の活性調節を介した新規AD治療法の開発 Invited

    祖父江 顕,小峯 起,遠藤史人,村山繁雄, 斎藤貴志,西道隆臣,山中宏二

    第41回日本認知症学会学術集会  2022.11.25 

     More details

    Event date: 2022.11

    Language:Japanese  

  4. アルツハイマー病におけるミクログリアのカンナビノイド受容体2型を介した神経炎症調節機序 Invited

    祖父江 顕,小峯 起,遠藤史人, 村山繁雄,斉藤貴志,西道隆臣,山中宏二

    NEURO2022  2022.6.30 

     More details

    Event date: 2022.6 - 2022.7

    Language:English   Presentation type:Poster presentation  

  5. Microglial cannabinoid receptor type II as a therapeutic target for Alzheimer’s disease

    2021.12.4 

     More details

    Event date: 2021.12

    Presentation type:Oral presentation (general)  

  6. アルツハイマー病の病態進行に伴いミクログリアの生理機能が低下する

    祖父江 顕,小峯 起,原 雄一郎, 遠藤史人,溝口博之,渡邊征爾,村山繁雄, 斉藤貴志,西道隆臣,佐原成彦,樋口真人, 荻 朋男,山中宏二

    第40回日本認知症学会学術集会  2021.11 

     More details

    Event date: 2021.11

    Language:Japanese   Presentation type:Poster presentation  

  7. Downregulation of homeostatic microglial genes is correlated with progression of Alzheimer's disease in mice

    Akira Sobue, Okiru Komine, Yuichiro Hara, Fumito Endo, Hiroyuki Mizoguchi, Seiji Watanabe, Shigeo Murayama, Takashi Saito, Takaomi C Saido, Naruhiko Sahara, Makoto Higuchi, Tomoo Ogi, Koji Yamanaka

    2021.7.31 

     More details

    Event date: 2021.7

    Language:English   Presentation type:Poster presentation  

  8. ミクログリアのカンナビノイド受容体2型を介したアルツハイマー病における神経炎症調節機構について

    ○祖父江顕、小峯起、遠藤史人、村山繁雄、斉藤貴志、西道隆臣、山中宏二

    第139回日本薬理学会近畿部会  2021.6.26 

     More details

    Event date: 2021.6

    Language:Japanese   Presentation type:Oral presentation (general)  

  9. ADにおけるミクログリアのカンナビノイド受容体2型を介した神経炎症調節機構について

    祖父江顕、小峯起、遠藤史人、村山繁雄、斉藤貴志、西道隆臣、山中宏二

    第39回日本認知症学会学術集会 

     More details

    Event date: 2020.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  10. ミクログリアのカンナビノイド 受容体2型を標的としたアルツハイマー病治療法開発 Invited

    祖父江 顕, 小峯 起, 遠藤 史人, 村山 繁雄, 斉藤 貴志, 西道 隆臣, 山中 宏二

    第1回脳科学サロン  2020.8.15 

     More details

    Event date: 2020.8

    Language:Japanese   Presentation type:Poster presentation  

  11. Microglial cannabinoid receptor type II as potential therapeutic target for Alzheimer's disease.

    Sobue A, Komine O, Endo F, Shigeo Murayama S, Saito T, Saido TC, Yamanaka K.

     More details

    Event date: 2020.2

    Language:English   Presentation type:Oral presentation (general)  

    Country:Japan  

  12. アルツハイマー病患者とAppNL-G-F マウスにおける神経炎症関連遺伝⼦解析

    祖父江 顕、小峯 起、遠藤史人、村山繁雄、斉藤貴志、西道隆臣、山中宏二

    第38回日本認知症学会学術集会 

     More details

    Event date: 2019.11

    Language:Japanese   Presentation type:Poster presentation  

    Venue:東京   Country:Japan  

  13. アルツハイマー病患者脳とAPP- KIマウス由来ミクログリアにおける遺伝子発現解析

    祖父江 顕、小峯 起、遠藤史人、村山繁雄、斉藤貴志、西道 隆臣、山中宏二

    第42回日本神経科学大会第62回日本神経化学会大会 

     More details

    Event date: 2019.7

    Language:Japanese   Presentation type:Poster presentation  

    Venue:新潟   Country:Japan  

  14. Profiling of gene expression in Alzheimer's disease patients and APP-KI mouse model demonstrates a link between amyloid pathology and microglial phenotype

    Akira Sobue, Okiru Komine, Fumito Endo, Shigeo Murayama, Koji Yamanaka

     More details

    Event date: 2019.2

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  15. 早期アルツハイマー病理を呈する患者脳における神経炎症関連遺伝子発現解析

    祖父江顕、遠藤史人、小峯起、村山繁雄、山中宏二

    第37回日本認知症学会学術集会 

     More details

    Event date: 2018.10

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

  16. The pathophysiological role of astroglial MHCI following systemic immune activation

    Akira Sobue, Norimichi Ito, Kazuhiro Hada, Akira Nakajima, Murakami Yuki, Mouri akihiro, Yamamoto Yasuko, Toshitaka Nabeshima, Kuniaki Saito, Taku Nagai, Kiyofumi Yamada

     More details

    Event date: 2018.8

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  17. The pathophysiological role of astroglial MHCI following immune activation

    Akira Sobue, Norimichi Ito, Wei Shan, Kazuhiro Hada, Akira Nakajima, Yuki Murakami, Akihiro Mouri, Yasuko Yamamoto, Toshitaka Nabeshima, Kuniaki Saito, Taku Nagai, Kiyofumi Yamada

     More details

    Event date: 2018.2

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  18. Astroglial MHCI following immune activation leads to behavioral and neuropathological abnormalities

    Akira Sobue, Norimichi Ito, Wei Shan, Kazuhiro Hada, Akira Nakajima, Yuki Murakami, Akihiro Mouri, Yasuko Yamamoto, Toshitaka Nabeshima, Kuniaki Saito, Taku Nagai, Kiyofumi Yamada

     More details

    Event date: 2017.12

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  19. Astroglial MHCI expression and its behavioral and neuropathological implications

     More details

    Event date: 2017.9

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  20. Peripheral immune activation leads to the expression of MHCI molecules in the cortex of mice.

     More details

    Event date: 2017.7

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  21. 末梢免疫活性が及ぼすマウス大脳皮質における免疫関連因子の発現誘導

    祖父江 顕, 伊藤 教道, 羽田 和弘, 中島 晶, 村上 由希, 毛利 彰宏, 山本 康子, 鍋島俊隆, 齋藤 邦明, 永井 拓, 山田 清文

    第 131 回日本薬理学会近畿部会  

     More details

    Event date: 2017.6

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  22. Exosomal MHCI derived from astrocytes leads to behavioral and neuropathological abnormalities in mice International conference

    Akira Sobue, Norimichi Ito, Kazuhiro Hada, Akira Nakajima, Toshitaka Nabeshima, Taku Nagai, Kiyofumi Yamada

    International Behavioral Neuroscience Society for the 26th Annual Meeting 

     More details

    Event date: 2017.6

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  23. Behavioral and neurochemical abnormalities in MHCI-expressed mice International conference

    Akira Sobue, Norimichi Ito, Kazuhiro Hada, Akira Nakajima, Toshitaka Nabeshima, Taku Nagai, Kiyofumi Yamada

    The 5th Congress of Asian College of Neuropsychopharmacology 

     More details

    Event date: 2017.4

    Language:English   Presentation type:Poster presentation  

    Country:Indonesia  

  24. Behavioral alterations accompanied by neuropathological changes induced by the expression of MHCI in the prefrontal cortex of mice

     More details

    Event date: 2017.3

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  25. Expression of MHCI in astrocyte leads to behavioral and neuropathological abnormalities

     More details

    Event date: 2017.2

    Language:English   Presentation type:Oral presentation (general)  

    Country:Japan  

  26. Reln rl-Orl/+ mice show behavioral abnormalities in emotion, social interaction and motor learning: association with dopaminergic dysfunction International conference

    Akira Sobue, Yuki Aoyama, Shan Wei, Taku Nagai, Kiyofumi Yamada

    Dopamine 2016 

     More details

    Event date: 2016.9

    Language:English   Presentation type:Poster presentation  

    Country:Austria  

  27. アストロサイトにおける MHC Class I の発現が行動に及ぼす影響と神経科学的解析

    祖父江顕、伊藤教道、羽田和弘、中島晶、永井拓、鍋島俊隆、山田清文

    第 18 回応用薬理シンポジウム 

     More details

    Event date: 2016.8

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  28. アストロサイトにおける MHCI の発現が社会性行動および認知機能へ及ぼす影響

    祖父江顕、伊藤教道、羽田和弘、中島晶、永井拓、鍋島俊隆、山田清文

    第 89 回日本薬理学会年会 

     More details

    Event date: 2016.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  29. 統合失調症モデルマウスとしての Orleans reeler マウスの行動評価と神経科学的解析

    祖父江顕、青山雄紀、Wei Shan、永井拓、山田清文

    第 25 回神経行動薬理若手研究者の集い  

     More details

    Event date: 2016.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  30. Expression of MHC class I gene in astrocytes impaires social behavior, cognitive function and sensorimotor gating in mice

     More details

    Event date: 2016.2

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  31. アストロサイトにおける MHC Class I の過剰発現が行動に及ぼす影響

    祖父江顕、伊藤教道、中島晶、永井拓、山田清文

    第 128 回日本薬理学会近畿部会  

     More details

    Event date: 2015.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  32. 中枢神経系における MHC Class I の細胞内局在と分泌機構について

    祖父江顕、伊藤教道、中島晶、永井拓、山田清文

    第 88 回日本薬理学会年 

     More details

    Event date: 2015.3

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  33. The localization and secretion of MHC class I molecules in neuronal and glial cells

     More details

    Event date: 2015.2

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  34. 認知症治療薬による錐体外路障害に対するセロトニン作用薬の評価

    祖父江顕、清水佐紀、水口裕登、藤原麻衣、森本朋樹、大野行弘

    第 63 回日本薬学会近畿支部総会・大会 

     More details

    Event date: 2013.10

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

  35. 認知症治療薬による錐体外路障害助長に対するセロトニン神経作用薬の影響

    祖父江顕、清水佐紀、水口裕登、藤原麻衣、森本朋樹、大野行弘

    生体機能と創薬シンポジウム 2013 

     More details

    Event date: 2013.8

    Language:Japanese   Presentation type:Poster presentation  

    Country:Japan  

▼display all

Research Project for Joint Research, Competitive Funding, etc. 1

  1. ミクログリアを標的としたアルツハイマー病治療標的探索と全身・脳連関機構の解明

    第30回研究費助成 

      More details

    Grant amount:\1000000

KAKENHI (Grants-in-Aid for Scientific Research) 4

  1. グリア細胞を標的としたアルツハイマー病における病態進行の分子機序の解明とその制御

    Grant number:23K14687  2023.4 - 2026.3

    名古屋大学  科学研究費助成事業  若手研究

    祖父江顕

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

  2. グリア細胞を標的としたアルツハイマー病の新規治療候補分子探索とその機能解析

    Grant number:20K16488  2020.4 - 2023.3

    科学研究費補助金  若手研究

      More details

    Authorship:Principal investigator 

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

  3. タンパク質の構造生物学に基づいた筋萎縮性側索硬化症の分子病態解明と治療法開発

    Grant number:19KK0214  2019.10 - 2024.3

    科学研究費補助金  国際共同研究加速基金(国際共同研究強化(B))

      More details

    Authorship:Coinvestigator(s) 

    Grant amount:\18330000 ( Direct Cost: \14100000 、 Indirect Cost:\4230000 )

  4. ミクログリアによる神経炎症に着目したアルツハイマー病の分子病態解明とその制御

    Grant number:19K21221  2018.8 - 2020.3

    科学研究費補助金  研究活動スタート支援

      More details

    Authorship:Principal investigator 

    Grant amount:\2990000 ( Direct Cost: \2300000 、 Indirect Cost:\690000 )

 

Teaching Experience (On-campus) 7

  1. 基盤医科学実習

    2023

  2. 基盤医科学実習

    2022

  3. 基盤医科学実習

    2021

  4. CIBoG卓越大学院 生命医科学基礎

    2021

  5. 基盤医科学実習

    2020

  6. 基盤医科学実習

    2019

  7. 基盤医科学実習

    2018

▼display all